JP2015521728A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521728A5
JP2015521728A5 JP2015516504A JP2015516504A JP2015521728A5 JP 2015521728 A5 JP2015521728 A5 JP 2015521728A5 JP 2015516504 A JP2015516504 A JP 2015516504A JP 2015516504 A JP2015516504 A JP 2015516504A JP 2015521728 A5 JP2015521728 A5 JP 2015521728A5
Authority
JP
Japan
Prior art keywords
expression level
compound
protein
genotoxic
ser1981
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015516504A
Other languages
English (en)
Japanese (ja)
Other versions
JP6301915B2 (ja
JP2015521728A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/001575 external-priority patent/WO2013185884A1/en
Publication of JP2015521728A publication Critical patent/JP2015521728A/ja
Publication of JP2015521728A5 publication Critical patent/JP2015521728A5/ja
Application granted granted Critical
Publication of JP6301915B2 publication Critical patent/JP6301915B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015516504A 2012-06-13 2013-05-28 遺伝毒性化合物を同定するためのタンパク質発現分析 Expired - Fee Related JP6301915B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261659024P 2012-06-13 2012-06-13
US61/659,024 2012-06-13
PCT/EP2013/001575 WO2013185884A1 (en) 2012-06-13 2013-05-28 Protein expression analyses for identifying genotoxic compounds

Publications (3)

Publication Number Publication Date
JP2015521728A JP2015521728A (ja) 2015-07-30
JP2015521728A5 true JP2015521728A5 (enExample) 2016-07-21
JP6301915B2 JP6301915B2 (ja) 2018-03-28

Family

ID=48536789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015516504A Expired - Fee Related JP6301915B2 (ja) 2012-06-13 2013-05-28 遺伝毒性化合物を同定するためのタンパク質発現分析

Country Status (9)

Country Link
US (1) US20150140123A1 (enExample)
EP (1) EP2861985B1 (enExample)
JP (1) JP6301915B2 (enExample)
CN (1) CN104364649B (enExample)
AU (1) AU2013276950B2 (enExample)
CA (1) CA2876402A1 (enExample)
ES (1) ES2660131T3 (enExample)
IL (1) IL236195B (enExample)
WO (1) WO2013185884A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9470694B2 (en) 2013-03-09 2016-10-18 Litron Laboratories Ltd. Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
US11513125B2 (en) * 2013-03-14 2022-11-29 Pioma, Inc. Microvesicle histone H2AX as a biomarker for genotoxic stress
CN104515760B (zh) * 2014-12-17 2017-10-31 深圳市纳观生物有限公司 双色荧光定位超分辨率生物显微方法及系统
WO2017145816A1 (ja) * 2016-02-24 2017-08-31 ソニー株式会社 光学測定器、フローサイトメータ、および放射線計数器
CN107159327B (zh) * 2017-05-17 2019-04-19 京东方科技集团股份有限公司 一种生物检测芯片及其检测方法
CN110333207A (zh) * 2019-06-25 2019-10-15 中国人民解放军陆军军医大学第一附属医院 CREB在Ang-2调节VEGFR2表达中分析方法
WO2021102420A1 (en) * 2019-11-22 2021-05-27 The Regents Of The University Of California Interferon signaling as a cancer biomarker
CN112680498A (zh) * 2020-12-28 2021-04-20 华南理工大学 一种遗传毒性物质的高通量筛查方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411198D0 (en) * 2004-05-20 2004-06-23 Gentronix Ltd Genotoxic testing
ATE480642T1 (de) * 2004-11-24 2010-09-15 Hoffmann La Roche Verfahren zur bestimmung von genotoxizität
JP2011505847A (ja) * 2007-12-20 2011-03-03 エフ．ホフマン−ラ ロシュ アーゲー 遺伝毒性の予測方法
GB0905410D0 (en) * 2009-03-28 2009-05-13 Gentronix Ltd Genotoxicity testing
DE102010024898B4 (de) * 2010-06-24 2012-10-25 Merck Patent Gmbh Genexpressionsanalysen zur Charakterisierung und Identifizierung genotoxischer Verbindungen

Similar Documents

Publication Publication Date Title
Kalu et al. Genomic characterization of human papillomavirus-positive and-negative human squamous cell cancer cell lines
Jahani-Asl et al. CDK5 phosphorylates DRP1 and drives mitochondrial defects in NMDA-induced neuronal death
Kuo et al. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
Arter et al. Virus–polymer hybrid nanowires tailored to detect prostate-specific membrane antigen
Cai et al. STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage
Lu et al. Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A
Xie et al. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a
JP2016500110A5 (enExample)
JP2014144959A5 (enExample)
Liu et al. Human papillomavirus as a favorable prognostic factor in a subset of head and neck squamous cell carcinomas: A meta‐analysis
Gusho et al. Human papillomaviruses target the DNA damage repair and innate immune response pathways to allow for persistent infection
Khan et al. Mercury exposure induces cytoskeleton disruption and loss of renal function through epigenetic modulation of MMP9 expression
Qiu et al. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells
Zhu et al. Hepatitis B virus X protein driven alpha fetoprotein expression to promote malignant behaviors of normal liver cells and hepatoma cells
Hu et al. Noninvasive diagnosis of nasopharyngeal carcinoma based on phenotypic profiling of viral and tumor markers on plasma extracellular vesicles
Taylor et al. Inhibition of TNF‐α‐induced activation of NF‐κB by hantavirus nucleocapsid proteins
Schultz et al. Tumor-promoting role of signal transducer and activator of transcription (Stat) 1 in late-stage melanoma growth
Li et al. PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancer
Koh et al. Epstein‐Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma
Graf et al. New insight into the phosphorylation-regulated intranuclear localization of human cytomegalovirus pUL69 mediated by cyclin-dependent kinases (CDKs) and viral CDK orthologue pUL97
Zhang et al. Targeting kinesins for therapeutic exploitation of chromosomal instability in lung cancer
Xie et al. Using proteomics to identify the HBx interactome in hepatitis B virus: how can this inform the clinic?
You et al. Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma
Arunima et al. CYP1B1-AS1 regulates CYP1B1 to promote Coxiella burnetii pathogenesis by inhibiting ROS and host cell death
CN103257167A (zh) 一种核酸适配体用于肿瘤细胞高灵敏检测的电极修饰方法